Inicia sesión Registrate Mi Biblioteca biblioteca abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.

98301 ARTíCULOS , VIENDO DEL 136 AL 150

PUBMED

Inositol Phosphates and Synthesizing Enzymes: Implications in Neurodegenerative Disorders

Onu CJ, Adu M, Chakkour M, Kumar V, Greenberg ML.

Biomolecules. 2025 Feb 4;15(2):225. doi: 10.3390/biom15020225.

0

0

0

PUBMED

The Heme Oxygenase/Biliverdin Reductase System and Its Genetic Variants in Physiology and Diseases

Mancuso C.

Antioxidants (Basel). 2025 Feb 6;14(2):187. doi: 10.3390/antiox14020187.

0

0

0

PUBMED

An autopsy case of coexisting spinal and bulbar muscular atrophy and multiple system atrophy

Miura M, Shintaku H, Numasawa Y, Ozaki K, Kanouchi T, Ishikawa K, Yokota T.

Neuropathology. 2025 Feb 6. doi: 10.1111/neup.13031. Online ahead of print.

0

0

0

PUBMED

Nano-mediated Management of Metal Toxicity-induced Neurodegeneration: A Critical Review

Dubey PR, Kaur G, Shukla R.

Mol Neurobiol. 2025 Feb 25. doi: 10.1007/s12035-025-04782-z. Online ahead of print.

0

0

0

PUBMED

Pathophysiological Significance of α-Synuclein in Sympathetic Nerves: In Vivo Observations

Isonaka R, Sullivan P, Goldstein DS.

Neurology. 2025 Feb 11;104(3):e210215. doi: 10.1212/WNL.0000000000210215. Epub 2025 Jan 13.

0

0

0

PUBMED

Mechanistic insights into connexin-mediated neuroglia crosstalk in neurodegenerative diseases

Denaro S, D'Aprile S, Vicario N, Parenti R.

Front Cell Neurosci. 2025 Feb 11;19:1532960. doi: 10.3389/fncel.2025.1532960. eCollection 2025.

0

0

0

PUBMED

An Update on Neuroaging on Earth and in Spaceflight

Kuznetsov NV, Statsenko Y, Ljubisavljevic M.

Int J Mol Sci. 2025 Feb 18;26(4):1738. doi: 10.3390/ijms26041738.

0

0

0

PUBMED

Artificial intelligence for identification of candidates for device-aided therapy in Parkinson's disease: DELIST-PD study

Freire-Álvarez E, Ramírez IL, García-Ramos R, Carrillo F, Santos-García D, Gómez-Esteban JC, Martínez-Castrillo JC, Martínez-Torres I, Madrid-Navarro CJ, Pérez-Navarro MJ, Valero-García F, Vives-Pasto

Comput Biol Med. 2025 Feb;185:109504. doi: 10.1016/j.compbiomed.2024.109504. Epub 2024 Dec 4.

0

0

0

PUBMED

Increased incidence of akinetic crises in Parkinson's disease patients treated with Levodopa-Carbidopa Intestinal Gel: A case series and review of the literature

Giannakis A, Tsamis K, Konitsiotis S.

Clin Neurol Neurosurg. 2025 Feb;249:108777. doi: 10.1016/j.clineuro.2025.108777. Epub 2025 Feb 4.

0

0

0

PUBMED

The Neurodegenerative Disease Knowledge Portal: Propelling Discovery Through the Sharing of Neurodegenerative Disease Genomic Resources

Dilliott AA, Costanzo MC, Bandres-Ciga S, Blauwendraat C, Casey B, Hoang Q, Iwaki H, Jang D, Kim JJ, Leonard HL, Levine KS, Makarious M, Nguyen TT, Rouleau GA, Singleton AB, Smadbeck P, Solle J, Vital

Neurol Genet. 2025 Feb 21;11(2):e200246. doi: 10.1212/NXG.0000000000200246. eCollection 2025 Apr.

0

0

0

PUBMED

Duration of "Good On" time per dose: Immediate-release carbidopa-levodopa vs. extended-release carbidopa-levodopa (IPX203, CREXONT®)

Hauser RA, Fernandez HH, Jimenez-Shahed J, Allard S, Banisadr G, Fisher S, D'Souza R.

Parkinsonism Relat Disord. 2025 Feb;131:107239. doi: 10.1016/j.parkreldis.2024.107239. Epub 2024 Dec 15.

0

0

0

PUBMED

Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial

Vijiaratnam N, Girges C, Auld G, McComish R, King A, Skene SS, Hibbert S, Wong A, Melander S, Gibson R, Matthews H, Dickson J, Carroll C, Patrick A, Inches J, Silverdale M, Blackledge B, Whiston J, Hu

Lancet. 2025 Feb 22;405(10479):627-636. doi: 10.1016/S0140-6736(24)02808-3. Epub 2025 Feb 4.

0

0

0

PUBMED

Increased vowel contrast and intelligibility in connected speech induced by sensorimotor adaptation

Beach SD, Johnson SA, Parrell B, Niziolek CA.

bioRxiv [Preprint]. 2025 Feb 13:2024.08.04.606537. doi: 10.1101/2024.08.04.606537.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neuroacademy